DiaSorin | Saluggia
LIAISON® XL | DiaSorin
DiaSorin | LinkedIn
Report on the Remuneration Policy
Italy's DiaSorin sees 60% plunge in COVID-19 revenue next year | Reuters
DiaSorin Italia S.p.A. | DiaSorin
DiaSorin | Saluggia
DiaSorin S.p.A. Completes Acquisition of the Focus Diagnostics' Molecular and Immunoassay Product Business from Quest Diagnostics
Covid-19 Tests in America: DiaSorin Gets FDA Emergency-Use Rights - Bloomberg
DiaSorin concludes acquisition of Luminex for $1.8bn
Homepage - DiaSorin Molecular
Annual Financial Report
DiaSorin - The Diagnostic Specialist
Azioni Diasorin: Analisi Tecnica - Borsa Italiana
Borsa: Milano recupera (-0,5%) con Mps, male Cnh e Diasorin - Notizie - Ansa.it
DiaSorin | Saluggia
Diasorin Launches LIAISON IQ POC Reader with 10-Minute SARS-CoV-2 Antibody Test - COVID-19 - mobile.Labmedica.com
DiaSorin Spa Italy - DiaSorin Molecular
DiaSorin S.p.A. (DSRL.F) Company Information - Simply Wall St
Annual Financial Report
Annual Financial Report
DiaSorin - The Diagnostic Specialist
DiaSorin announces the launch of a fully automated serology test to detect antibodies against SARS-CoV-
Liaison XL. Soluciones para el inmunodiagnóstico. - YouTube
Results | DiaSorin
DiaSorin Molecular LLC | LinkedIn
MeMed partners with Italy's DiaSorin to commercialize bacteria vs virus test | The Times of Israel
DiaSorin Inc. | DiaSorin
DiaSorin S.p.A. (DIA) Company Information - Simply Wall St
DiaSorin Molecular LLC | LinkedIn
DiaSorin : Incorporating medium-term hiccups; but re-rating potential remains intact
Kinetics and seroprevalence of SARS-CoV-2 antibodies: a comparison of 3 different assays | Scientific Reports
DiaSorin Molecular LLC | LinkedIn
DIASORIN S.p.A. REPORT ON THE REMUNERATION POLICY AND FEES PAID 2020
REPORT ON THE REMUNERATION POLICY FOR THE YEAR 2022 AND REMUNERATION PAID IN THE YEAR 2021 OF DIASORIN S.p.A.
Annual Financial Report
Shares in Diasorin surge ahead of coronavirus diagnostic test launch
DiaSorin: Overvalued Italian Healthcare Company (OTCMKTS:DSRLF) | Seeking Alpha
DiaSorin Molecular Receives FDA Clearance for Reliable C. difficile Assay on LIAISON MDX Platform | Technology Networks
DiaSorin - The Diagnostic Specialist
Minnesota State College Southeast - News, Events, and Updates
COVID-19 | Updates | DiaSorin
Relazione_CG_Esercizio_31 12 2008_en
Results | DiaSorin
Results | DiaSorin
DiaSorin Molecular LLC | LinkedIn
DiaSorin S.p.A. : Shareholders Board Members Managers and Company Profile | IT0003492391 | MarketScreener
DiaSorin Inc. | LinkedIn
DiaSorin | Saluggia
Borsa: Milano in calo (-0,45%), cede Diasorin, balza Mps - Notizie - Ansa.it
DiaSorin : Taking on board the near-term difficulties -August 16, 2023 at 05:46 am| MarketScreener
/cloudfront-us-east-2.images.arcpublishing.com/reuters/34L6IFUZ2JLLDHCVNW34Y664HE.jpg "Italy's DiaSorin sees 60% plunge in COVID-19 revenue next year | Reuters")
Italy's DiaSorin sees 60% plunge in COVID-19 revenue next year | Reuters
COVID-19 | Updates | DiaSorin
